Patent · US Active

Use of HMGB1 for protection against ischemia reperfusion injury

US7829097B2 · kind B2 · utility

3Cited by

5References

30Claims

0Family size

Assignees

University of Pittsburgh—Of the Commonwealth System of Higher Education · US
The Feinstein Institutes for Medical Research · US

Inventors

Allan Tsung · Pittsburgh, US
Timothy Billiar · Pittsburgh, US
Mitchell P. Fink · Pittsburgh, US
Kevin J. Tracey · Stamford, US

Key dates

Filing date	Feb 6, 2007
Grant date	Nov 9, 2010
Priority date	—
Expiry date	May 5, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions are disclosed for protecting an organ or tissue from inflammation and organ injury following ischemia, reperfusion, and trauma through the administration of an HMGB1 protein within a time period sufficient to protect the organ or tissue from injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.